A COST-EFFECTIVENESS ANALYSIS BETWEEN RADIOFREQUENCY CATHETER ABLATION (RFCA) AND ANTI-ARRHYTHMIC DRUG IN THE TREATMENT OF CHINESE PATIENTS WITH ATRIAL FIBRILLATION (AF)
机构：[1]Anzhen Hosp, Beijing, Peoples R China;首都医科大学附属安贞医院[2]Johnson & Johnson Med China Ltd, Shanghai, Peoples R China;[3]Centennial Sci Co Ltd, Alpharetta, GA USA;[4]Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China
出处：
ISSN：
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2016]版：
大类|2 区医学
小类|2 区卫生保健与服务
最新[2025]版：
大类|2 区医学
小类|2 区卫生保健与服务2 区卫生政策与服务3 区经济学
JCR分区：
出版当年[2015]版：
Q1HEALTH CARE SCIENCES & SERVICESQ1HEALTH POLICY & SERVICESQ1ECONOMICS
最新[2024]版：
Q1ECONOMICSQ1HEALTH CARE SCIENCES & SERVICESQ1HEALTH POLICY & SERVICES
Du X.,Guo L.,He X.,et al.A COST-EFFECTIVENESS ANALYSIS BETWEEN RADIOFREQUENCY CATHETER ABLATION (RFCA) AND ANTI-ARRHYTHMIC DRUG IN THE TREATMENT OF CHINESE PATIENTS WITH ATRIAL FIBRILLATION (AF)[J].VALUE IN HEALTH.2017,20(5):A249-A249.
APA：
Du, X.,Guo, L.,He, X.,Jia, Y.,Wu, J....&Ma, C..(2017).A COST-EFFECTIVENESS ANALYSIS BETWEEN RADIOFREQUENCY CATHETER ABLATION (RFCA) AND ANTI-ARRHYTHMIC DRUG IN THE TREATMENT OF CHINESE PATIENTS WITH ATRIAL FIBRILLATION (AF).VALUE IN HEALTH,20,(5)
MLA：
Du, X.,et al."A COST-EFFECTIVENESS ANALYSIS BETWEEN RADIOFREQUENCY CATHETER ABLATION (RFCA) AND ANTI-ARRHYTHMIC DRUG IN THE TREATMENT OF CHINESE PATIENTS WITH ATRIAL FIBRILLATION (AF)".VALUE IN HEALTH 20..5(2017):A249-A249
